Publications from 2021 to 2026
Filter Showing 10 of 3,506 papers
Corrigendum to "Inhibition of lysophosphatidic acid receptor 1 attenuates neuroinflammation via PGE2/EP2/NOX2 signalling and improves the outcome of intracerebral haemorrhage in mice" [Brain Behav. Immun. 91 (2021) 615-626
Retraction Notice to "G-CSF Attenuates Neuroinflammation and Stabilizes the Blood-Brain Barrier via the PI3K/Akt/GSK-3β Signaling Pathway Following Neonatal Hypoxia-Ischemia in Rats" [Experimental Neurology 272 (2015) 135-144
Retraction Notice to "ErbB4 protects against neuronal apoptosis via activation of YAP/PIK3CB signaling pathway in a rat model of subarachnoid hemorrhage" [Experimental Neurology 297 (2017) 92-100
Wellness testing in blood donation: A framework for responsible innovation.
Publisher Correction: Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database.
Abstract No. 101 Efficacy of Biliary Drainage in Achieving Target Bilirubin Levels for Subsequent Chemotherapy Administration in Patients with Pre-drainage Bilirubin Levels >10 mg/dL
26-CCC-12613-ACC MULTIMODALITY IMAGING OF CHRONIC CONSTRICTIVE PERICARDITIS FOLLOWING VIRAL PNEUMONIA
26-CCC-19085-ACC FINDING A BROKEN HEART IN THE HEART - SINUS OF VALSALVA RUPTURE INTO THE RIGHT ATRIUM
Global Burden of Sickle Cell Disease: Adequacy of Pain Control as Evidenced by Frequency of Oral Pain Medication Use, Health Outcomes, and Emotional Well-Being Across Diverse Populations.
Sickle cell disease (SCD) is a chronic genetic disorder causing severe pain, anemia, and systemic complications that negatively affect patients' physical and mental well-being. The aim of this global cross-sectional study was to evaluate the relationship between oral pain medication (OPM) use frequency and health outcomes, emotional well-being, social participation, and satisfaction with care among people with SCD. Data were collected via an online survey across five continents from February to September 2024. A total of 123 participants were divided into two groups based on OPM use frequency: weekly or more (n=62) and once or twice a month (n=61). Participants in OPM weekly group reported poorer self-rated health, shortness of breath, more frequent hospitalizations, and missed school days due to SCD crises compared to the monthly group (p<0.05). However, use of treatments such as hydroxyurea and preventive screenings like transcranial Doppler was similar across groups. Emotional well-being also significantly differed in the weekly group, with lower happiness levels, difficulty in emotional regulation, and reduced social participation (p<0.01). Satisfaction with medical care was significantly lower among weekly OPM users (p<0.001). These findings suggest that higher OPM use is associated with poorer physical, emotional, and social outcomes. The results highlight the importance of comprehensive and multidisciplinary care approaches that may support the overall well-being of individuals with SCD and utilize OPM as a relevant clinical metric to assess disease burden in SCD. The authors have confirmed clinical trial registration is not needed for this submission.
Read moreAbstract No. 112 Predictive Value of TI-RADS Scores for Thyroidectomy and Assessment of Inter-rater Variability
Copyright 2026 Cactus Communications. All rights reserved.
